Spectral Med Stock Forward View - Simple Exponential Smoothing
| EDT Stock | CAD 1.29 0.01 0.78% |
For short-term price forecasting, Spectral Med's sentiment profile - captured through news flow and social engagement - can be as informative as any financial ratio. This module quantifies and translates that data into a price signal.
According to momentum metrics, Spectral Med reflects the 14-period RSI of 0, indicating compressed downside momentum. At these depths, Spectral Med may be approaching exhaustion on the sell side, though timing a reversal requires additional confirmation.Momentum
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter -0.02 | EPS Estimate Current Year -0.08 | EPS Estimate Next Year -0.04 | Wall Street Target Price 3.1 | EPS Estimate Current Quarter -0.01 |
This section frames Spectral Med response to recent headlines in a peer context.
The Simple Exponential Smoothing forecasted value of Spectral Med on the next trading day is expected to be 1.29 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 1.38.Spectral Med after-hype prediction price | C$ 1.29 |
This view helps relate attention signals to forecasting and technical indicators plus earnings context.
Spectral |
Spectral Med Additional Predictive Modules
Most predictive techniques to examine Spectral price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Spectral using various technical indicators. When you analyze Spectral charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Simple Exponential Smoothing Price Forecast For the 15th of March 2026
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Spectral Med on the next trading day is expected to be 1.29 with a mean absolute deviation of 0.02 , mean absolute percentage error of 0.001 , and the sum of the absolute errors of 1.38 .Please note that although there have been many attempts to predict Spectral Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Spectral Med's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Spectral Med | Spectral Med Price Prediction | Research Analysis |
Forecasted Value
This next-day forecast for Spectral Med uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Spectral Med stock data series using in forecasting. Note that when a statistical model is used to represent Spectral Med stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.2259 |
| Bias | Arithmetic mean of the errors | -2.0E-4 |
| MAD | Mean absolute deviation | 0.0226 |
| MAPE | Mean absolute percentage error | 0.0168 |
| SAE | Sum of the absolute errors | 1.3776 |
The degree to which Spectral Med's exhibits mean reversion depends on how efficiently the market prices new information. In highly covered equities, the mean reversion window tends to be shorter.
After-Hype Price Density Analysis
The after-hype price distribution for Spectral Med helps investors understand how much of Spectral Med's predicted return comes from the central scenario versus tail outcomes. Strategies that rely on tail events for Spectral Med are inherently more speculative.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
Historical news patterns for Spectral Med reveal how the market has historically digested different types of information about Spectral Med's business and market environment. Spectral Med's after-hype downside and upside margins for the prediction period are 0.06 and 3.82, respectively. The model extrapolates these patterns to estimate likely price boundaries following the next significant.
Current Value
The after-hype framework applied to Spectral Med assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Spectral Med is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Spectral Med backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Spectral Med, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.04 | 2.53 | 0.00 | 0.00 | 5 Events | 2 Events | In 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.29 | 1.29 | 0.00 |
|
Hype Timeline
Spectral Med is currently traded for 1.29on Toronto Exchange of Canada. The company stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Spectral is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.04%. %. The volatility of related hype on Spectral Med is about 5060.0%, with the expected price after the next announcement by competition of 1.29. About 18.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.14. Spectral Med last dividend was issued on the 19th of December 2011. Assuming the 90-day trading horizon the next anticipated press release will be in 5 days. Historical Fundamental Analysis of Spectral Med provides a cross-check on projections for Spectral Med. The analysis adds historical context for the projection set.Related Hype Analysis
Peer hype analysis helps investors build a more complete picture of Spectral Med's competitive environment by quantifying the market's sensitivity to news across all major players in Spectral Med's sector.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HITI | High Tide | 0.08 | 4 per month | 0.00 | -0.0018 | 3.85 | -4.77 | 19.30 | |
| CPH | Cipher Pharmaceuticals | -0.34 | 3 per month | 1.25 | 0.10 | 3.73 | -2.48 | 8.20 | |
| ACB | Aurora Cannabis | 0.13 | 8 per month | 0.00 | -0.07 | 5.75 | -5.91 | 30.59 | |
| FRX | Fennec Pharmaceuticals | 0.00 | 8 per month | 2.29 | 0.03 | 5.68 | -4.64 | 22.70 | |
| WEED | Canopy Growth Corp | -0.01 | 7 per month | 4.20 | 0.01 | 6.62 | -7.77 | 65.32 | |
| EPRX | Eupraxia Pharmaceuticals | -0.03 | 9 per month | 2.31 | 0.11 | 6.09 | -4.05 | 21.64 | |
| KSI | Kneat Inc | 0.31 | 6 per month | 0.00 | -0.11 | 3.95 | -5.05 | 16.35 | |
| PRN | Profound Medical Corp | -0.54 | 9 per month | 0.00 | -0.03 | 5.62 | -5.51 | 37.88 |
Other Forecasting Options for Spectral Med
The price trajectory of Spectral is the primary concern for any investor assessing it as an opportunity. Spectral Stock price charts are filled with noise that can easily mislead uninformed investment decisions.Spectral Med Related Equities
The following equities are related to Spectral Med within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Spectral Med against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Spectral Med Market Strength Events
Understanding the market strength of Spectral Med stock enables investors to assess the security's momentum and responsiveness to broader market forces. These indicators are essential tools for timing trades in Spectral Med with greater precision.
| Accumulation Distribution | 509.4 | |||
| Daily Balance Of Power | 0.3333 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 1.29 | |||
| Day Typical Price | 1.29 | |||
| Price Action Indicator | 0.01 | |||
| Period Momentum Indicator | 0.01 |
Spectral Med Risk Indicators
Reviewing Spectral Med's basic risk indicators is essential for investors who want to forecast its price and manage their investment risk effectively. This analysis helps identify the amount of risk involved in holding Spectral Med's and informs decisions about hedging and position.
| Mean Deviation | 1.72 | |||
| Standard Deviation | 2.45 | |||
| Variance | 6.02 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Spectral Med
Coverage intensity for Spectral Med matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Other Macroaxis Stories
Story coverage on Macroaxis is built for readers who approach markets from different levels of experience but share the same need for disciplined investment context. Used well, these stories become part of a broader workflow built around idea generation, validation, and risk-adjusted portfolio design.
Story Categories
Currently Trending Categories
Spectral Med Short Properties
Short sentiment tied to Spectral Med matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 281.1 M | |
| Cash And Short Term Investments | 3 M |
More Resources for Spectral Stock Analysis
Other Information on Investing in Spectral Stock
Spectral Med financial ratios provide valuation context across profits, cash flow, and enterprise value. They help compare Spectral across valuation measures in a consistent way.